TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SYRINX Bioanalytics Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2014/12 | 2013/12 |
Turnover |
14,762
|
12,380
|
12,967 |
Financial expenses |
191
|
266
|
259 |
Earnings before taxes |
383
|
95
|
376 |
Total assets |
6,209
|
4,948
|
3,783 |
Current assets |
0
|
3,309 | |
Current liabilities |
2,038
|
1,437
|
1,458 |
Equity capital |
823
|
514
|
393 |
- share capital |
29
![]() |
29
|
27 |
Employees (average) |
14
![]() |
14
|
13 |
Financial ratios
Fiscal year | 2016/12 | 2014/12 | 2013/12 |
Solvency |
13.3%
|
10.4%
![]() |
10.4% |
Turnover per employee |
1,054
|
884
|
997 |
Profit as a percentage of turnover |
2.6%
|
0.8%
|
2.9% |
Return on assets (ROA) |
9.2%
|
7.3%
|
16.8% |
Current ratio |
0%
|
227.0% | |
Return on equity (ROE) |
46.5%
|
18.5%
|
95.7% |
Change turnover |
2,315
|
-1,418
|
7,137 |
Change turnover % |
19%
|
-10%
|
122% |
Chg. No. of employees |
0
|
1 | |
Chg. No. of employees % |
0%
|
8% |
Total value of public sale
Fiscal year | 2016/12 | 2014/12 | 2013/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.